Sonic Healthcare stock gets a Hold rating with an AUD 19.90 target

Published on 10/08/2026 at 03:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sonic Healthcare stock stood at AUD 18.76 on the ASX on October 8, 2026, while Ord Minnett set an AUD 19.90 target. FY2026 revenue reached AUD 10.9 billion.

Sonic, AU000000SHL7, Illustration mit AI erstellt.

Sonic Healthcare stock was last at AUD 18.76 on the ASX on October 8, 2026 at 10:50 a.m. AEST, down AUD 0.07 or 0.37 percent from the prior close. The latest analyst action came from Ord Minnett, which maintained a Hold rating and set an AUD 19.90 price target on October 4, 2026, according to Markets Insider.

Ord Minnett keeps a Hold view

The AUD 19.90 target stands 6.1 percent above the AUD 18.76 share price. Ord Minnett's stance therefore points to a measured valuation view rather than a fresh upgrade, while the target remains above the latest ASX quote.

The same Markets Insider report cites quarterly revenue of AUD 5.54 billion and net profit of AUD 345.81 million for the quarter ended June 30, 2026. The prior-year comparison was AUD 4.98 billion in revenue and AUD 276.91 million in net profit.

FY2026 growth meets execution risks

Sonic Healthcare's Investor Centre listed FY2026 revenue of AUD 10.9 billion, underlying EBITDA of AUD 1.93 billion and underlying net profit of AUD 621 million on October 7, 2026, in its annual report announcement at Sonic Healthcare. The figures show the scale of the diagnostics group's earnings base after its recent expansion.

FY2026 underlying net profit was 17 percent higher than the prior year, while revenue increased 13 percent to AUD 10.9 billion, according to Middle News. The counterweight is execution: the company faces Swiss fee reductions, a delayed United Kingdom contract ramp-up and integration demands linked to its LADR acquisition.

Stock remains below its yearly high

At AUD 18.76, Sonic Healthcare stock was 22.7 percent below its 52-week high of AUD 24.27 and above its 52-week low of AUD 18.26 on October 8, 2026. The market capitalization was AUD 9.3 billion and volume stood at 323,641 shares at the same time.

Consensus estimates published by Investing.com show a Neutral view from 16 analysts, comprising 4 Buy, 9 Hold and 3 Sell ratings. The average 12-month target was AUD 22.46, with a high of AUD 27.50 and a low of AUD 19.60, putting the average target 19.7 percent above the October 8 price.

ASX quote stays below AUD 19.00

Sonic Healthcare stock was last at AUD 18.76 on the ASX on October 8, 2026, with the session range at AUD 18.56 to AUD 18.77. The market is weighing a solid FY2026 earnings base against the execution issues reflected in the Hold rating.